TY  - ADVS
AU  - Tang,Patricia
TI  - Phase II trials
T2  - Cancer therapy : latest thinking in efficacy and toxicity,
PY  - 2021///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Development
KW  - Clinical trials
KW  - Design
KW  - Drug development
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Clinical Trials, Phase II as Topic
KW  - Endpoint Determination
KW  - Imatinib Mesylate
KW  - Patient Selection
KW  - Randomized Clinical Trials as Topic
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Clinical trial endpoints -- Response rate -- Progression-free survival -- Phase II trial designs -- Randomized phase II -- Enrichment -- Basket and umbrella trials; Access restricted to subscribers
UR  - https://hstalks.com/bs/4697/
UR  - https://hstalks.com/bs/p/385/
ER  -